PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAJ3. A total of 8 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 10,344,000 | $9,921,000 | 5.62% |
Soros Fund Management | 17,624,000 | $16,577,000 | 0.46% |
Pinnacle Holdings, LLC | 1,000,000 | $930,625,000 | 0.35% |
WOLVERINE ASSET MANAGEMENT LLC | 11,852,000 | $11,136,000 | 0.14% |
LAZARD ASSET MANAGEMENT LLC | 12,000,000 | $11,287,000 | 0.02% |
Citadel Advisors | 22,733,000 | $21,352,000 | 0.01% |
DEUTSCHE BANK AG\ | 10,500,000 | $9,771,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |